Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 bli Supply Disruption — Pfizer Inc. (Low Risk — Unlik
Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 bli Supply Disruption — Pfizer Inc. (Low Risk — Unlik is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 bli; Manufacturer: Pfize
| Drug name | Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 bli |
|---|---|
| Manufacturer | Pfizer Inc. |
| Recall/Disruption reason | Failed Dissolution Specifications |
| Risk classification | Low Risk — Unlikely to Cause Adverse Health Effects |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-1342-2020 |
| Initiation date | 20200527 |
| Quantity affected | 544400 packages |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →